Skip to main content
. 2020 Jun 14;10(6):904. doi: 10.3390/biom10060904

Figure 15.

Figure 15

(a) Two compounds that exerted neuroprotection by epigenetically-promoted upregulation of NRF2 expression. (b) Schisandrin B exerted neuroprotection in a Parkinson’s disease (PD) cell model by blocking the suppression of NRF2 activity by the microRNA miR-34a.